Novavax Inc at Bank of America Healthcare Conference Transcript
Hello, everyone. Welcome to the final session of day 2 of the 2022 Bank of America Healthcare Conference, and thank you for joining this session with Novavax. My name is Alec Stranahan. I'm Vice President and senior biotech analyst here at BofA, and I'm pleased to be joined by John Trizzino, Chief Commercial Officer and Chief Business Officer; and Greg Glenn, President of Research and Development. And maybe we'll just jump right in to the Q&A.
Questions & Answers
So John, you guys -- you had your 1Q print yesterday. Maybe you could just set the stage by going through your business and sort of what we saw in the 1Q print.
Sure. Alec, thank you very much. I think the most exciting about our earnings call this past week is our first quarter of revenue-generating business, so
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
